FH Europe News

Paediatric screening and Technical Meeting

Paediatric screening and Technical Meeting

FH Europe is embarking on one of its biggest programmes yet - to ensure familial hypercholesterolaemia (FH) paediatric screening is made available, throughout the EU and wider Europe, to all who need and choose it. Together with renowned clinical experts in the field...

We refine our vision and purpose 

We refine our vision and purpose 

FH Europe is committed to improving lives of families affected by inherited dyslipidaemias FH Europe is a non-profit organisation in the patient advocacy space, founded as a network of European patient organisations which share the same purpose. We face an environment...

HEART BEAT NEWS – JULY 2021

HEART BEAT NEWS – JULY 2021

Read the July edition of FH Europe’s Heart Beat newsletter: In this edition: Watch the FH Roundtable discussion from EAS Congress: Next steps after the Global Call to Action on FH. Discover news from The Czech Republic about new alirocumab treatments available. Read...

HEART BEAT NEWS – JULY 2021

FH Europe Heart Beat News – June 2021

Right from the start, June has been very busy and packed with important updates. This month, we announce a joint statement from 12 leading CVD organisations to the EU. As the European Atherosclerosis Society hosted its annual conference, we bring the latest about patient online events in local languages by our members, Harteraad – The Netherlands, FHChol – Austria and CholCo E.V – Germany. You can also learn more about HEART UK’s Medical & Scientific Virtual Conference 2021

Call for EU Plan on CVD

Call for EU Plan on CVD

FH Europe joins forces with European and international health organizations to call for action to address the increasing burden of cardiovascular disease (CVD). Rochester, UK 16 June 2021: Today, 12 European and international health organizations signed a joint...

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt
Site by: Vovi Web Design